Advertisement
News
Subscribe to MDT Magazine News

NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients

December 12, 2010 5:33 am | by Bio-Medicine.Org | Comments

SAN ANTONIO, and SAN FRANCISCO, Dec. 12, 2010 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer...

TOPICS:

Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine

December 12, 2010 2:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 12, 2010 /- Pfizer Inc. (NYSE: PFE ) announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of...

TOPICS:

SABCS 2010: Interview with C. Kent Osborne, M.D.(2)

December 11, 2010 5:35 pm | by AACR | Comments

Dr. Osborne talks about the most compelling research presented at the symposium this year, his long association with the SABCS and his vision for its future.

TOPICS:
Advertisement

SABCS 2010: Interview with C. Kent Osborne, M.D.

December 11, 2010 5:35 pm | Comments

Dr. Osborne talks about the most compelling research presented at the symposium this year, his long association with the SABCS and his vision for its future.

SABCS 2010: Interview with Eric P. Winer, M.D.

December 11, 2010 12:31 pm | by AACR | Comments

SABCS 2010: Interview with Eric P. Winer, M.D., director of the Breast Oncology Center and Thompson senior investigator in breast cancer research at Dana-Farber Cancer Institute; professor of Medicine at Harvard Medical School Dr. Winer discusses breast cancer screening, the clinical...

TOPICS:

SABCS 2010: Interview with Robert E. Coleman, M.D.

December 11, 2010 10:31 am | by AACR | Comments

Dr. Coleman, chief investigator of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial, presents the rationale for studying the bisphosphonate zoledronic acid, and the final results of this study.

TOPICS:

SABCS 2010: Interview with Paul Workman, Ph.D., F.Med.Sci.

December 11, 2010 6:37 am | by AACR | Comments

Dr. Workman defines molecular chaperones and discusses their role in the cell, stress response pathways, heat shock proteins and the potential of this line of breast cancer research.

TOPICS:

SABCS 2010: Interview with Rowan T. Chlebowski, M.D. Ph.D.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Chlebowski, lead investigator for the Women's Health Initiative, discusses the initiative's findings about the use of hormone therapy and its influence on cancer incidence and related cancer mortality, and the effects of bisphosphonates on breast cancer risk.

TOPICS:
Advertisement

SABCS 2010: Interview with Laura Esserman, M.D., M.B.A.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Esserman discusses her philosophy of holistic treatment and involving patients in the decision-making process, a cancer risk tracking system, and the I-Spy trials that match treatments to patients based on biomarkers.

TOPICS:

SABCS 2010: Interview with Klaus Pantel, M.D., Ph.D.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Pantel discusses his findings about micrometastasis that contradict long-held beliefs about metastasis, and the implications of these discoveries for the treatment of breast cancer.

TOPICS:

SABCS 2010: Interview with Edith A. Perez, M.D.

December 11, 2010 6:35 am | by AACR | Comments

In this podcast, Dr. Perez discusses ALTTO (the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), the role of genetic markers in breast cancer treatment, the challenges of treating patients with triple-negative breast cancer, and the promise of personalized medicine.

TOPICS:

SABCS 2010: Interview with Charles M. Perou, Ph.D.

December 11, 2010 6:35 am | by AACR | Comments

Dr. Perou talks about genomic and genetic approaches to characterizing diverse breast cancers and their unique biologic features, using next-generation sequencing, and the implications of this science for clinical use.

TOPICS:

SABCS 2010: Interview with Rochelle Shoretz

December 11, 2010 6:35 am | by AACR | Comments

Ms. Shoretz talks about the mission of Sharsheret, how she came to establish this nonprofit organization, and her appointment to a federal advisory committee on breast cancer in young women.

TOPICS:

SABCS 2010: Interview with Sandi Stanford

December 11, 2010 6:34 am | by AACR | Comments

Ms. Stanford talks about the mission of the Alamo Breast Cancer Foundation and how advocates can take an active role in breast cancer research.

TOPICS:

SABCS 2010: HER2 Teleconference

December 11, 2010 5:34 am | by AACR | Comments

Neil Spector, M.D., professor of medicine at Duke University Medical Center, hosts this press conference.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading